Business Context and Reporting Period
Company: Organigram Holdings Inc. (Foreign Private Issuer)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: December 2024 (Material Change Report dated December 16, 2024)
Key Event: The filing incorporates a Share Purchase Agreement dated December 6, 2024, regarding the acquisition of Motif Labs Ltd.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a material corporate transaction rather than periodic financial results.
Material Changes
- Acquisition: Organigram Holdings Inc. entered into a Share Purchase Agreement with the shareholders of Motif Labs Ltd. on December 6, 2024.
- Regulatory Action: The Material Change Report and the Share Purchase Agreement are incorporated by reference into the company's Registration Statement on Form F-10 (File No. 333-274686).
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, financial guidance, or a detailed risk assessment beyond the disclosure of the material change. The primary focus is the execution of the acquisition agreement.
Key Facts for Investor Verification
- Verify the terms and consideration of the Share Purchase Agreement with Motif Labs Ltd. (Exhibit 99.2).
- Review the full Material Change Report (Exhibit 99.1) for details on the strategic rationale and potential impact.
- Check the status of the Registration Statement on Form F-10 (File No. 333-274686) to which this filing is incorporated.